Predictors of clinical trial discontinuation in trichotillomania: a secondary analysis of previous clinical trials
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Participant discontinuation in trichotillomania (hair-pulling disorder) trials is common. Higher education levels and a history of depression predict higher dropout rates, informing future retention strategies.
Area Of Science
- Psychiatry
- Clinical Psychology
- Pharmacological Research
Background
- Participant discontinuation presents a significant challenge in trichotillomania (hair-pulling disorder) pharmacological trials.
- High attrition rates reduce statistical power, introduce bias, and increase resource expenditure in clinical studies.
- Identifying predictors of discontinuation is crucial for enhancing participant retention and improving study outcomes.
Purpose Of The Study
- To investigate demographic and clinical variables associated with participant discontinuation in trichotillomania pharmacological trials.
- To identify key factors that predict dropout risk in individuals undergoing treatment for hair-pulling disorder.
- To inform strategies for improving participant retention in future clinical research.
Main Methods
- Aggregated data from five completed pharmacological trials for trichotillomania.
- Classified 222 participants into 'Discontinued' (20%) and 'Completed' (80%) groups.
- Analyzed differences in demographic and clinical variables using a generalized linear mixed model.
Main Results
- Participants who discontinued treatment were more likely to have higher levels of formal education.
- A history of depression was significantly associated with a higher likelihood of participant discontinuation.
- Approximately 20% of participants discontinued their participation in the trials.
Conclusions
- This study is among the first to examine predictors of discontinuation in trichotillomania trials.
- Educational background and a history of depression are important factors to consider when assessing dropout risk.
- Findings can guide future research to better support participants at risk of discontinuing treatment, improving retention and study validity.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
One influential perspective on what motivates people's behavior is detailed in Tory Higgin's self-discrepancy theory (Higgins, 1987). He proposed that people hold disagreeing internal representations of themselves that lead to different emotional states.
According to the self-discrepancy theory, people hold beliefs about what they’re really like—their actual self—as well as what they would ideally like to be—their ideal...
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...